MedTrace Logo

Goal Directed Therapy After Aneurysmal Subarachnoid Haemorrhage

NCT01832389 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2019-03-13

No results posted yet for this study

Summary

The objective of this study is to determine whether a goal-directed therapy can reduce the incidence of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage.

Conditions

  • Aneurysmal Subarachnoid Haemorrhage
  • SAH

Interventions

DEVICE

PiCCO

Sponsors & Collaborators

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Bettina Jungwirth, MD · Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München

  • Aida Anetsberger, MD · Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-11-30
Completion
2016-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01832389 on ClinicalTrials.gov